(0.16%) 5 477.90 points
(0.04%) 39 128 points
(0.49%) 17 805 points
(0.06%) $80.88
(-5.04%) $2.62
(-0.90%) $2 309.80
(-0.36%) $28.77
(2.90%) $1 015.00
(0.34%) $0.936
(0.66%) $10.67
(0.50%) $0.792
(0.87%) $88.25
0.82% $ 182.19
@ $180.84
Emitido: 26 jun 2024 @ 14:39
Retorno: 0.75%
Señal anterior: jun 26 - 09:46
Señal anterior:
Retorno: 2.13 %
Live Chart Being Loaded With Signals
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States...
Stats | |
---|---|
Volumen de hoy | 353 152 |
Volumen promedio | 380 859 |
Capitalización de mercado | 5.20B |
EPS | $0.0300 ( Q4 | 2024-05-06 ) |
Próxima fecha de ganancias | ( $0.460 ) 2024-08-05 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
83.19 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $5.30 (2.91%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-11 | Krishnan Suma | Sell | 1 100 | Common Stock |
2024-06-11 | Krishnan Suma | Sell | 1 882 | Common Stock |
2024-06-11 | Krishnan Suma | Sell | 1 318 | Common Stock |
2024-06-11 | Krishnan Suma | Sell | 4 000 | Common Stock |
2024-06-11 | Krishnan Suma | Sell | 4 550 | Common Stock |
INSIDER POWER |
---|
-68.29 |
Last 100 transactions |
Buy: 51 800 | Sell: 265 300 |
Volumen Correlación
Krystal Biotech Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
TRVI | 0.925 |
APLT | 0.922 |
NNOX | 0.915 |
KELYA | 0.914 |
HOOD | 0.91 |
BCYC | 0.91 |
TSHA | 0.905 |
ACVA | 0.902 |
OSS | 0.901 |
BTF | 0.899 |
10 Correlaciones Más Negativas | |
---|---|
DBX | -0.941 |
SABR | -0.935 |
RAPT | -0.934 |
ROKU | -0.918 |
MFIN | -0.909 |
SSP | -0.881 |
FIVN | -0.869 |
AUPH | -0.865 |
CYAN | -0.863 |
GASS | -0.862 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Krystal Biotech Inc Correlación - Moneda/Commodity
Krystal Biotech Inc Finanzas
Annual | 2023 |
Ingresos: | $50.70M |
Beneficio Bruto: | $42.60M (84.02 %) |
EPS: | $0.400 |
FY | 2023 |
Ingresos: | $50.70M |
Beneficio Bruto: | $42.60M (84.02 %) |
EPS: | $0.400 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-4.05M (0.00 %) |
EPS: | $-5.49 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-3.13 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Krystal Biotech Inc
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome. Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx product. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico